Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Donate to our blog

Your support will help Science & Enterprise continue to provide science news for business people and business news for scientists.

Univ. Spin-Off Offering Pediatric Care Software

A company spun-off from Indiana University is marketing software written in its medical school to relate pediatric clinical guidelines to parents’ concerns during office visits. . . . → Read More: Univ. Spin-Off Offering Pediatric Care Software

Protein Drug Discovery Company Launches, Gains $50M

A biotechnology enterprise founded by faculty at Scripps Research Institute plans to discover new therapies based on complex interactions with human proteins. . . . → Read More: Protein Drug Discovery Company Launches, Gains $50M

Asthma Drug Tested as Alcoholism Treatment

Results from a small-scale clinical trial show an established drug to treat asthma and other inflammatory conditions has promise as a treatment for alcohol dependence. . . . → Read More: Asthma Drug Tested as Alcoholism Treatment

Immunotherapy Biotech Raises $102 Million in IPO

A biotechnology company developing treatments for solid tumors, harnessing the body’s immune system, for cancer patients most likely to respond is raising $102 million in its initial public stock offering. . . . → Read More: Immunotherapy Biotech Raises $102 Million in IPO

Simpler Lab Cell Production Techniques Devised

A process is being developed that makes it easier to produce healthy and diseased cells in the lab from human specimens for regenerative medicine and research. . . . → Read More: Simpler Lab Cell Production Techniques Devised

Lilly Acquires Migraine Therapy Company in $960M Deal

Drug maker Eli Lilly and Company is acquiring CoLucid Pharmaceuticals, a developer of treatments for migraine pain and associated symptoms. . . . → Read More: Lilly Acquires Migraine Therapy Company in $960M Deal

Scripps, Pfizer Collaborate on DNA-Coded Drug Discovery

Drug maker Pfizer Inc. is gaining access to advances in a synthetic chemistry technology developed by Scripps Research Institute that tags compounds with DNA identifiers. . . . → Read More: Scripps, Pfizer Collaborate on DNA-Coded Drug Discovery

Sanofi Licensing Antibody for Autoimmune Diseases

The global drug company Sanofi is licensing a synthetic antibody to treat autoimmune disorders being developed by a spin-off enterprise from Dartmouth College. . . . → Read More: Sanofi Licensing Antibody for Autoimmune Diseases

Ionis Options Cardiac Drugs in $1.5 Billion Deal

Biotechnology company Ionis Pharmaceuticals is providing drug maker Novartis first access to two experimental drugs for controlling proteins that promote cholesterol and triglycerides, which contribute to heart disease. . . . → Read More: Ionis Options Cardiac Drugs in $1.5 Billion Deal

FDA Approves Spinal Muscular Atrophy Drug [Updated]

A drug to treat spinal muscular atrophy, a genetic disorder causing the wasting away of muscle tissue in children and adults, was approved for sale in the U.S. . . . → Read More: FDA Approves Spinal Muscular Atrophy Drug [Updated]